Anavex Life Sciences Corp elects John Harrison to Scientific Advisory Board.
M2 EQUITYBITES-December 11, 2013-Anavex Life Sciences Corp elects John Harrison to Scientific Advisory Board
(C)2013 M2 COMMUNICATIONS http://www.m2.com
Biopharmaceutical company Anavex Life Sciences Corp (OTC Markets:AVXL) revealed on Tuesday the election of John Harrison, PhD, to its Scientific Advisory Board.
The company added that Dr Harrison is an internationally acknowledged specialist for design of human clinical outcome measurement in Alzheimer's disease and other cognitive impairments. He has successfully integrated cognitive testing into drug development programmes for many pharmaceutical and biotechnology companies.
Currently, Dr Harrison is a honorary senior lecturer in the Department of Medicine at Imperial College in London, a member of the American Psychological Association, a principal consultant at Metis Cognition Ltd as well as holding chartered psychologist status with the British Psychological Society and chartered scientist status with the UK Science Council.
Previously, Dr Harrison was employed as head of Neuropsychology at CeNeS Pharmaceuticals, principal consultant at CPC Pharma Services and principal scientist at CogState Ltd.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Dec 11, 2013|
|Previous Article:||Santander to purchase 8% stake in Bank of Shanghai.|
|Next Article:||Draft tax legislation published by UK government.|